Tag Archive | "Merck"
Infants’ Mylicon Gas Relief Dye Free Drops Recalled
Johnson and Johnson–Merck Consumer Pharmaceuticals Company Announces Urgent Voluntary Nationwide Recall Of Infants’ Mylicon Gas Relief Dye Free Drops (Simethicone-Antigas) Non-Staining Due To Possible Metal Fragments Johnson & Johnson • Merck Consumer Pharmaceuticals Company (JJMCP) is voluntarily recalling approximately 12,000 units of Infants’ MYLICON® GAS RELIEF DYE FREE drops (simethicone-antigas) non-staining sold in 1 oz. plastic [...]
Continue reading...Merck’s Vioxx $4.85 billion payouts to begin in August
Sunday, July 27, 2008
Merck & Company will begin funding cto resolve state and federal claims over its painkiller Vioxx. The first payment of $500 million is scheduled for August 6; additional payments will follow. Merck said it met its threshold to make these payouts and waived its right to walk away from last November’s agreement to settle roughly [...]
Continue reading...Merck recalls Vioxx
Sunday, July 27, 2008
Arthritis drug Vioxx (Rofecoxib) has been voluntarily recalled by Merck & Co Inc. worldwide. The move to pull the COX-2 inhibitor off the market on September 30, 2004 shocked the arthritis world and rocked the stock value of Merck. The Reason The decision to recall Vioxx followed a three year trial, known as APPROVe (Adenomatous Polyp Prevention on [...]
Continue reading...Arthritis Drug Vioxx Recalled
Sunday, July 27, 2008
Arthritis drug Vioxx (Rofecoxib) was recalled by Merck & Co., Inc. The Vioxx recall was voluntarily started by Merck to discontinue the COX-2 inhibitor in September, 2004. Person’s affected by the Vioxx side effects are urged to seek medical and legal help. The Vioxx Recall was prompted after a three year trial known as Adenomatous Polyp [...]
Continue reading...FDA Issues Public Health Advisory on Vioxx
Thursday, July 3, 2008
The Food and Drug Administration has issued a public health advisory to inform people of the voluntary withdrawal from the market of Vioxx (rofecoxib) by its maker, Merck & Co. Inc., on Sept. 30, 2004. The agency advisory says people who used the nonsteroidal anti-inflammatory drug (NSAID) should consult with a physician about alternative medications. Merck [...]
Continue reading...
Tuesday, November 18, 2008
0 Comments